Printer Friendly

BURROUGHS WELLCOME CO. APPOINTS NEW VICE PRESIDENT, MARKETING AND SALES

BURROUGHS WELLCOME CO. APPOINTS NEW VICE PRESIDENT, MARKETING AND SALES
 RESEARCH TRIANGLE PARK, N.C., June 23 /PRNewswire/ -- Burroughs Wellcome Co. has announced that Mark D. Perrin has been named Vice President, Marketing and Sales. He replaces Tim Rothwell who has accepted the position of President and CEO of Sandoz Pharmaceuticals Corporation. In order to facilitate a smooth transition, the appointment will become effective over the next several weeks.
 Perrin joins Burroughs Wellcome from Lederle, the pharmaceutical division of American Cyanamid (NYSE: ACY), where he held the position of Vice President and General Manager for Lederle Pharmaceuticals. His career at Lederle encompassed a broad experience in sales and marketing of both prescription and consumer products, including assignments as Division Manager for Canadian operations and Vice President and General Manager for Consumer Health Products. He also served as product manager for all anti infective products and as group product manager for vaccines/biologicals and other related product lines.
 Commenting on the announcement, Philip R. Tracy, Burroughs Wellcome President and CEO, noted, "We are very fortunate to have someone with Mark's experience and track record join our company. We regret Tim's decision to leave Wellcome but wish him well in his new role. We feel the accomplishments achieved under his leadership provide a solid foundation for the future of our business. Mark's expertise is a natural fit for the product lines of Burroughs Wellcome and we are confident of our continued growth under his direction."
 -0- 6/23/92
 /CONTACT: Kathy S. Bartlett, Burroughs Wellcome Co., 919-248-4302/
 (ACY) CO: Burroughs Wellcome, Co. ST: North Carolina IN: MTC SU: PER


JZ -- CH003 -- 2847 06/23/92 12:23 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 23, 1992
Words:276
Previous Article:LA SALSA MEXICAN RESTAURANTS COMPLETES GROWTH FINANCING
Next Article:STOCKS ON AMEX'S NEW EMERGING COMPANY MARKETPLACE OUTPERFORM NASDAQ COMPOSITE INDEX BY MORE THAN 17 PERCENT OVER PAST FOUR MONTHS
Topics:


Related Articles
DR. GERTRUDE ELION INDUCTED INTO WOMEN'S HALL OF FAME
CYTRX NAMES FRANCIS J. CASIERI TO HEAD EXPANDING OPERATIONS
COPLEY PHARMACEUTICAL, INC. NAMES GABRIEL R. CIPAU, PH.D., PRESIDENT, CEO AND BOARD MEMBER;
COPLEY PHARMACEUTICAL, INC. APPOINTS EXECUTIVE VICE PRESIDENT, OPERATIONS
MEDCO RESEARCH APPOINTS ANNE MCKAY DIRECTOR OF REGULATORY AFFAIRS
SUNPHARM ELECTS PHILIP TRACY TO BOARD OF DIRECTORS New Seat Created for Former President and CEO of Burroughs Wellcome
MEDCO RESEARCH APPOINTS MICHAEL FREEMAN MANAGER OF CORPORATE COMMUNICATIONS
MEDCO RESEARCH APPOINTS GLENN ANDREWS CHIEF FINANCIAL OFFICER
DR. DANNIE H. KING NAMED PRESIDENT AND CHIEF OPERATING OFFICER OF VYREX CORPORATION
CYTOTHERAPEUTICS ELECTS SANDRA NUSINOFF LEHRMAN, M.D., PRESIDENT AND CHIEF OPERATING OFFICER

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters